Abbott (ABT) Tops Q3 EPS by 1c; Narrows, Boosts FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Abbott Reports Third-Quarter 2016 Results
October 19, 2016 7:45 AM EDTABBOTT PARK, Ill., Oct. 19, 2016 /PRNewswire/ -- Abbott (NYSE: ABT)Â today announced financial results for the third quarter ended Sept. 30, 2016.
Third-quarter worldwide sales of $5.3 billion increased 2.9 percent on a reported basis and 4.0 percent on an operational basis. Reported diluted EPS from continuing operations under GAAP was a $(0.24) loss in the third quarter, primarily due to an adjustment of $(0.66) per share associated with Abbott's equity investment in Mylan to reflect Mylan's share price as of Sept. 30, 2016. Excluding specified items, adjusted diluted EPS from continuing operations was... More